FR2465479A1 - Comprime a deux couches contenant chacune une prodrogue d'antibiotique differente - Google Patents
Comprime a deux couches contenant chacune une prodrogue d'antibiotique differente Download PDFInfo
- Publication number
- FR2465479A1 FR2465479A1 FR8020247A FR8020247A FR2465479A1 FR 2465479 A1 FR2465479 A1 FR 2465479A1 FR 8020247 A FR8020247 A FR 8020247A FR 8020247 A FR8020247 A FR 8020247A FR 2465479 A1 FR2465479 A1 FR 2465479A1
- Authority
- FR
- France
- Prior art keywords
- layer
- active ingredient
- tablet
- tablet according
- ampicillin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229960000723 ampicillin Drugs 0.000 title abstract description 8
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 title abstract description 8
- 229940024554 amdinocillin Drugs 0.000 title abstract description 6
- BWWVAEOLVKTZFQ-ISVUSNJMSA-N chembl530 Chemical compound N(/[C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)=C\N1CCCCCC1 BWWVAEOLVKTZFQ-ISVUSNJMSA-N 0.000 title abstract description 6
- 230000000844 anti-bacterial effect Effects 0.000 title abstract description 3
- 239000002243 precursor Substances 0.000 title abstract 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims abstract description 8
- 150000002148 esters Chemical class 0.000 claims abstract description 8
- -1 pivaloyloxymethyl Chemical group 0.000 claims abstract description 8
- RBKMMJSQKNKNEV-RITPCOANSA-N penicillanic acid Chemical compound OC(=O)[C@H]1C(C)(C)S[C@@H]2CC(=O)N21 RBKMMJSQKNKNEV-RITPCOANSA-N 0.000 claims abstract 3
- 239000004480 active ingredient Substances 0.000 claims description 14
- 229940002612 prodrug Drugs 0.000 claims description 10
- 239000000651 prodrug Substances 0.000 claims description 10
- 239000007884 disintegrant Substances 0.000 claims description 5
- 239000012752 auxiliary agent Substances 0.000 claims description 4
- 239000011248 coating agent Substances 0.000 claims description 4
- 238000000576 coating method Methods 0.000 claims description 4
- 239000000969 carrier Substances 0.000 claims description 2
- 239000012458 free base Substances 0.000 claims description 2
- 231100000252 nontoxic Toxicity 0.000 claims 1
- 230000003000 nontoxic effect Effects 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- ZEMIJUDPLILVNQ-ZXFNITATSA-N pivampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)[C@H](C(S3)(C)C)C(=O)OCOC(=O)C(C)(C)C)=CC=CC=C1 ZEMIJUDPLILVNQ-ZXFNITATSA-N 0.000 description 13
- 229960003342 pivampicillin Drugs 0.000 description 13
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 12
- 239000008187 granular material Substances 0.000 description 11
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 10
- 229920002472 Starch Polymers 0.000 description 9
- 239000008107 starch Substances 0.000 description 9
- 235000019698 starch Nutrition 0.000 description 9
- 239000000203 mixture Substances 0.000 description 8
- UHPXMYLONAGUPC-WKLLBTDKSA-N pivmecillinam hydrochloride Chemical compound [H+].[Cl-].N([C@H]1[C@@H]2N(C1=O)[C@H](C(S2)(C)C)C(=O)OCOC(=O)C(C)(C)C)=CN1CCCCCC1 UHPXMYLONAGUPC-WKLLBTDKSA-N 0.000 description 7
- 229940037380 pivmecillinam hydrochloride Drugs 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 239000000945 filler Substances 0.000 description 6
- 235000019359 magnesium stearate Nutrition 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 5
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 5
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 5
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 229920000609 methyl cellulose Polymers 0.000 description 5
- 239000001923 methylcellulose Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- NPGNOVNWUSPMDP-UTEPHESZSA-N chembl1650818 Chemical compound N(/[C@H]1[C@@H]2N(C1=O)[C@H](C(S2)(C)C)C(=O)OCOC(=O)C(C)(C)C)=C\N1CCCCCC1 NPGNOVNWUSPMDP-UTEPHESZSA-N 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 239000011159 matrix material Substances 0.000 description 4
- 229960004212 pivmecillinam Drugs 0.000 description 4
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 3
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 2
- 239000008108 microcrystalline cellulose Substances 0.000 description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 125000005205 alkoxycarbonyloxyalkyl group Chemical group 0.000 description 1
- 238000007098 aminolysis reaction Methods 0.000 description 1
- MDFFNEOEWAXZRQ-UHFFFAOYSA-N aminyl Chemical compound [NH2] MDFFNEOEWAXZRQ-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 238000004880 explosion Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000003979 granulating agent Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 150000002960 penicillins Chemical class 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB7932902 | 1979-09-21 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2465479A1 true FR2465479A1 (fr) | 1981-03-27 |
| FR2465479B1 FR2465479B1 (enExample) | 1984-11-02 |
Family
ID=10508005
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR8020247A Granted FR2465479A1 (fr) | 1979-09-21 | 1980-09-19 | Comprime a deux couches contenant chacune une prodrogue d'antibiotique differente |
Country Status (8)
| Country | Link |
|---|---|
| AT (1) | AT371711B (enExample) |
| AU (1) | AU532764B2 (enExample) |
| DE (1) | DE3035509A1 (enExample) |
| FR (1) | FR2465479A1 (enExample) |
| IT (1) | IT1209809B (enExample) |
| NL (1) | NL8005252A (enExample) |
| NZ (1) | NZ194785A (enExample) |
| SE (1) | SE444887B (enExample) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2158427A1 (enExample) * | 1971-11-01 | 1973-06-15 | Astra Laekemedel Ab | |
| FR2270875A1 (enExample) * | 1974-05-17 | 1975-12-12 | Sarath |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1405866A (en) * | 1919-12-12 | 1922-02-07 | Frank X Ratkovic | Planting machine |
-
1980
- 1980-08-27 NZ NZ194785A patent/NZ194785A/xx unknown
- 1980-09-15 AT AT0461480A patent/AT371711B/de not_active IP Right Cessation
- 1980-09-19 FR FR8020247A patent/FR2465479A1/fr active Granted
- 1980-09-19 SE SE8006592A patent/SE444887B/sv not_active IP Right Cessation
- 1980-09-19 AU AU62564/80A patent/AU532764B2/en not_active Ceased
- 1980-09-19 NL NL8005252A patent/NL8005252A/nl not_active Application Discontinuation
- 1980-09-19 IT IT8068456A patent/IT1209809B/it active
- 1980-09-19 DE DE19803035509 patent/DE3035509A1/de not_active Withdrawn
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2158427A1 (enExample) * | 1971-11-01 | 1973-06-15 | Astra Laekemedel Ab | |
| FR2270875A1 (enExample) * | 1974-05-17 | 1975-12-12 | Sarath |
Also Published As
| Publication number | Publication date |
|---|---|
| DE3035509A1 (de) | 1981-04-09 |
| AT371711B (de) | 1983-07-25 |
| IT8068456A0 (it) | 1980-09-19 |
| IT1209809B (it) | 1989-08-30 |
| AU532764B2 (en) | 1983-10-13 |
| NL8005252A (nl) | 1981-03-24 |
| FR2465479B1 (enExample) | 1984-11-02 |
| SE8006592L (sv) | 1981-03-22 |
| AU6256480A (en) | 1981-04-09 |
| NZ194785A (en) | 1983-05-31 |
| ATA461480A (de) | 1982-12-15 |
| SE444887B (sv) | 1986-05-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2804333C (fr) | Formulations a base de nalbuphine et leurs utilisations | |
| AU2002230217B2 (en) | Tablets quickly disintegrated in oral cavity | |
| EP2349217B1 (fr) | Granulé d'acide gamma-hydroxybutyrique | |
| BE1004229A5 (fr) | Agents pharmaceutiques. | |
| EP2464333B1 (fr) | Microgranulés flottants | |
| CA2652023C (fr) | Nouvelle forme d'administration du racecadotril | |
| EP1919473B1 (fr) | Association d'un agent hypnotique a duree d'action longue et d'un agent hypnotique a duree d'action courte et son application therapeutique | |
| EP0673245B1 (fr) | Composition pharmaceutique effervescente contenant de l'ibuprofene et son procede de preparation | |
| EA038435B1 (ru) | Применение фармацевтической композиции в виде таблетки с пленочным покрытием для лечения сахарного диабета 2 типа | |
| FR2781793A1 (fr) | Procede de fabrication de granules de gabapentine enrobes | |
| EP1126829B1 (fr) | Particules enrobees d'ibuprofene cristallin granule | |
| CA2123232C (fr) | Compositions pharmaceutiques a base d'ebastine ou de ses analogues | |
| IL107870A (en) | Pharmaceutical compositions having an antidepressant activity comprising pramipexol | |
| UA124663C2 (uk) | Таблетка | |
| EP1054672B1 (fr) | Microgranules de sulfate de morphine, procede de fabrication et preparations pharmaceutiques | |
| EP1646379B1 (fr) | Nouvelle composition pharmaceutique solide comprenant de l amisulpride | |
| EP0868184B1 (fr) | Microgranules a liberation prolongee contenant du diltiazem comme principe actif | |
| BE883390A (fr) | Derives de l'acide penicillanique utiles comme medicaments, compositions therapeutiques les contenant et procedes de leur preparation | |
| BE1010972A6 (fr) | Composition pharmaceutique antituberculeuse et procede destine a produire ladite composition. | |
| EP2349226A1 (fr) | Nouveau procédé de préparation de granulés de principes actifs, et granulés tels qu'obtenus | |
| FR2465479A1 (fr) | Comprime a deux couches contenant chacune une prodrogue d'antibiotique differente | |
| FR2489146A1 (fr) | Composition pharmaceutique a liberation prolongee a base d'une substance medicamenteuse solide | |
| EP1646373B1 (fr) | Composition pharmaceutique orodispersible d'un compose antithrombotique | |
| FR2467596A1 (fr) | Compositions pharmaceutiques de tiaramide ou de son sel et d'un agent reglant la dissolution, a longue duree d'action | |
| EP0340105A1 (fr) | Microbilles de diltiazem, leur procédé de fabrication et compositions pharmaceutiques à libération prolongée les contenant |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| TP | Transmission of property | ||
| ST | Notification of lapse |